2Lalli C,Cioffetta M,Del Sindaco P,et al.Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime[J].Diabetes Care,1999,22:468.
3Boskovic R,Feig DS,Derewlany L,et al.Transfer of insulin lispro across human placenta:in vitro perfusion studies[J].Diabetes Care,2003,26:1390-1394.
4Greenspa FS,Gaardner DG.Basic and Clinical Endocrinology.The seventh edition[M].The McGraw-Hill Companies,2004:701.
5Heller SR,Colagiuri S,Vaaler S,et al.Hypoglycaemia with insulin apart:a double-blind,randomised,crossover trial in subjects with type 1 diabetes[J].Diabet Med,2004,21:769-775.
6Danne T,Aman J,Schober E,et al.A comparison of postprandial administration of insulin aspart in children and adolescents with type 1 diabetes[J].Diabetes Care,2003,26:2359 -2364.
7Home P,Lindholn A,Piis A.Impoved long-term controll with insulin aspart versus human insulin in people with type 1 diabetes[J].Diabetes,1999,48 (1):358.
8Vehkavaara S,Yki-Jarvinen H.3.Five years of insulin glargine improves in vivo endothelial function in type 2 diabetes[J].Arterioscler Thromb Vasc Biol,2004,24:325-330.
9Tschritter O,Porubska K,Hennige AM,et al.Neuronal activation of the human cerebral cortex by administration of insulin determir compared to human insulin[J].Diabetologia,2005,48(1):256.
10Dreyer M,Prager R,Rbinson A,et al.Efficacy and safety of insulin glulisine in patients with type 1 diabetes[J].Horm Metab Res,2005,37:702-707.
